We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-1.55%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$41.7B
AUM Growth
+$2.19B
Cap. Flow
+$590M
Cap. Flow %
1.42%
Top 10 Hldgs %
9.51%
Holding
3,328
New
131
Increased
1,345
Reduced
1,491
Closed
336
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBH icon
2176
Prestige Consumer Healthcare
PBH
$2.6B
$1.09M ﹤0.01%
33,752
-5,552
-14% -$186K
AMSF icon
2177
AMERISAFE
AMSF
$540M
$1.09M ﹤0.01%
27,917
-4,917
-15% -$189K
AGO icon
2178
Assured Guaranty
AGO
$3.34B
$1.08M ﹤0.01%
48,938
+4,104
+9% +$95.5K
BSD
2179
DELISTED
The BlackRock Strategic Municipal Trust
BSD
$1.08M ﹤0.01%
81,382
-5,455
-6% -$72.1K
HCSG icon
2180
Healthcare Services Group
HCSG
$1.53B
$1.08M ﹤0.01%
37,725
+4,629
+14% +$129K
NVX
2181
DELISTED
Nuveen Calif Div Muni
NVX
$1.07M ﹤0.01%
77,491
+5,322
+7% +$73.4K
VTN icon
2182
Invesco Trust for Investment Grade New York Municipals
VTN
$168M
$1.07M ﹤0.01%
79,711
+9,873
+14% +$136K
PLXS icon
2183
Plexus
PLXS
$7.23B
$1.07M ﹤0.01%
28,895
+405
+1% +$16.4K
AMTD
2184
DELISTED
TD Ameritrade Holding Corp
AMTD
$1.06M ﹤0.01%
31,901
+14,833
+87% +$480K
BRKR icon
2185
Bruker
BRKR
$8.14B
$1.06M ﹤0.01%
57,245
+28,187
+97% +$602K
EPI icon
2186
WisdomTree India Earnings Fund ETF
EPI
$2.06B
$1.06M ﹤0.01%
+48,364
New +$1.09M
XLRN
2187
DELISTED
Acceleron Pharma
XLRN
$1.06M ﹤0.01%
35,038
-2,514
-7% -$70.8K
THO icon
2188
Thor Industries
THO
$4.14B
$1.05M ﹤0.01%
20,487
-2,287
-10% -$122K
EGN
2189
DELISTED
Energen
EGN
$1.05M ﹤0.01%
14,608
-4,083
-22% -$327K
CWEI
2190
DELISTED
Clayton Williams Energy, Inc.
CWEI
$1.05M ﹤0.01%
10,947
-1,565
-13% -$181K
ZU
2191
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
$1.05M ﹤0.01%
27,841
+13,369
+92% +$484K
EQY
2192
DELISTED
Equity One
EQY
$1.05M ﹤0.01%
48,521
-9,520
-16% -$222K
DHY
2193
Credit Suisse High Yield Credit Fund
DHY
$240M
$1.04M ﹤0.01%
338,046
-20,622
-6% -$65.5K
PRDO icon
2194
Perdoceo Education
PRDO
$2.12B
$1.04M ﹤0.01%
205,529
-4,638
-2% -$23.8K
PRSU
2195
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
$1.04M ﹤0.01%
50,536
-1,108
-2% -$24.5K
CXT icon
2196
Crane NXT
CXT
$3.07B
$1.04M ﹤0.01%
47,504
-37,729
-44% -$914K
TV icon
2197
Televisa
TV
$1.49B
$1.04M ﹤0.01%
30,653
+2,480
+9% +$88.2K
AUQ
2198
DELISTED
AURICO GOLD INC COM
AUQ
$1.04M ﹤0.01%
297,819
-10,519
-3% -$43.3K
TRI icon
2199
Thomson Reuters
TRI
$44.1B
$1.03M ﹤0.01%
24,477
-10,089
-29% -$436K
RNF
2200
DELISTED
RENTECH NITROGEN PARTNERS, L.P. INT
RNF
$1.03M ﹤0.01%
82,732
-18,506
-18% -$282K

Similar funds

Guggenheim Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Guggenheim Capital held 3,328 positions worth $41.7B, up 5.5% from $39.5B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Guggenheim Capital's Q3 2014 filing shows 131 new, 1,345 increased, 1,491 reduced and 336 closed positions. Its largest new stake was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M. The largest sale was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, an estimated $98.4M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Guggenheim Capital's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M.
  • Guggenheim Capital added most to CLAYMORE GUGGENHEIM BULLETSHARES 2015 CORP BD ETF in Q3 2014, an estimated $96.3M increase.
  • Guggenheim Capital's biggest Q3 2014 reduction was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, cutting an estimated $98.4M.
  • Guggenheim Capital fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $40.1M.
  • Guggenheim Capital's ten largest holdings make up 9.5% of its $41.7B portfolio in Q3 2014.
  • Guggenheim Capital opened 131 new positions and closed 336 in Q3 2014.
  • Guggenheim Capital's portfolio value rose 5.5% quarter-over-quarter to $41.7B.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.